Close

Pacira Pharma (PCRX): EXPAREL Sales Are Tracking Below Consensus - Wedbush

September 21, 2016 8:16 AM EDT Send to a Friend
Wedbush analyst, Liana Moussatos, reiterated her Outperform rating on shares of Pacira Pharmaceuticals (NASDAQ: PCRX) while noting that the Symphony ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login